UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses

The Journal of clinical investigation, 2022-03, Vol.132 (5), p.1-9

2022

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

The Journal of clinical investigation, 2021-05, Vol.131 (10)

2021

Link zum Volltext

Verfügbarkeit prüfen

CD8 Effector T Cells Function Synergistically With Broadly Neutralizing Antibodies to Enhance Suppression of HIV Infection

Frontiers in immunology, 2021-07, Vol.12, p.708355-708355

2021

Link zum Volltext

Verfügbarkeit prüfen

A T Cell Receptor Sequencing-Based Assay Identifies Cross-Reactive Recall CD8 + T Cell Clonotypes Against Autologous HIV-1 Epitope Variants

Frontiers in immunology, 2020-04, Vol.11, p.591-591

2020

Link zum Volltext

Verfügbarkeit prüfen

Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses

PloS one, 2018-02, Vol.13 (2), p.e0192098-e0192098

2018

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection

EBioMedicine, 2022-06, Vol.80, p.104048-104048, Article 104048

2022

Link zum Volltext

Verfügbarkeit prüfen

mRNA Vaccine-Elicited Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells Persist at 6 Months and Recognize the Delta Variant

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e898-e901

2022

Link zum Volltext

Verfügbarkeit prüfen

The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)

Clinical infectious diseases, 2022-04, Vol.74 (7), p.1268-1270

2022

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2-specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge

JCI insight, 2022-05, Vol.7 (10)

2022

Link zum Volltext

Verfügbarkeit prüfen

Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses

The Journal of clinical investigation, 2021-05, Vol.131 (10), p.1-15

2021

Link zum Volltext

Verfügbarkeit prüfen

Elite suppressors have low frequencies of intact HIV-1 proviral DNA

AIDS (London), 2020-03, Vol.34 (4), p.641-643

2020

Link zum Volltext

Verfügbarkeit prüfen

Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients

Clinical infectious diseases, 2022-10, Vol.75 (9), p.1652-1654

2022

Link zum Volltext

Verfügbarkeit prüfen

A CD3/CD28 microbead-based HIV-1 viral outgrowth assay

Journal of Virus Eradication, 2017-04, Vol.3 (2), p.85-89

2017

Link zum Volltext

Verfügbarkeit prüfen

Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV

AIDS (London), 2022-07, Vol.36 (9), p.1315-1317

2022

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of Different Immune Activation Strategies to Reverse HIV-1 Latency

Open forum infectious diseases, 2020-04, Vol.7 (4), p.ofaa082-ofaa082

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-term remission despite clonal expansion of replication-competent HIV-1 isolates

JCI insight, 2018-09, Vol.3 (18)

2018

Link zum Volltext

Verfügbarkeit prüfen

Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections

The Lancet. Microbe, 2022-09, Vol.3 (9), p.e644-e644

2022

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 mRNA vaccines induce broad [CD4.sup.+] T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

The Journal of clinical investigation, 2021-05, Vol.131 (10)

2021

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 mRNA vaccines induce broad CD4 T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

The Journal of clinical investigation, 2021-05, Vol.131 (10), p.1-6

2021

Link zum Volltext

Verfügbarkeit prüfen

T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses

The Journal of clinical investigation, 2022-03, Vol.132 (5)

2022

Link zum Volltext

Verfügbarkeit prüfen

Decay of COVID-19 mRNA vaccine-induced immunity in people living with HIV

AIDS (London), 2022-07, Vol.36 (9), p.1315-1317

2022

Link zum Volltext

Verfügbarkeit prüfen

Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient

Clinical infectious diseases, 2022-04

2022

Link zum Volltext

Verfügbarkeit prüfen

Cross-reactive microbial peptides can modulate HIV-specific CD8.sup.+ T cell responses.(Research Article)(human immunodeficiency virus)

PloS one, 2018-02, Vol.13 (2), p.e0192098

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(26)
Journals@Ovid Complete
(15)
MEDLINE
(14)
IngentaConnect Journals
(7)
Ingenta
(7)
Publisher website
(7)
Oxford University Press Journals Current
(4)
Oxford Journals 2020 Medicine
(4)
JSTOR Complete Journals
(3)

4 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses

SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

CD8 Effector T Cells Function Synergistically With Broadly Neutralizing Antibodies to Enhance Suppression of HIV Infection

A T Cell Receptor Sequencing-Based Assay Identifies Cross-Reactive Recall CD8 + T Cell Clonotypes Against Autologous HIV-1 Epitope Variants

Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses

SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection

mRNA Vaccine-Elicited Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells Persist at 6 Months and Recognize the Delta Variant

The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)

SARS-CoV-2-specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge

Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses

Elite suppressors have low frequencies of intact HIV-1 proviral DNA

Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients

A CD3/CD28 microbead-based HIV-1 viral outgrowth assay

Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV

A Comparison of Different Immune Activation Strategies to Reverse HIV-1 Latency

Long-term remission despite clonal expansion of replication-competent HIV-1 isolates

Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections

Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection

SARS-CoV-2 mRNA vaccines induce broad [CD4.sup.+] T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

SARS-CoV-2 mRNA vaccines induce broad CD4 T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses

Decay of COVID-19 mRNA vaccine-induced immunity in people living with HIV

Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient

Functional characterization of [CD4.sup.+] T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses

Cross-reactive microbial peptides can modulate HIV-specific CD8.sup.+ T cell responses.(Research Article)(human immunodeficiency virus)

Suchergebnisse filtern